HP-211 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10 (month) in 2mo
ESTIMATED |
READOUT
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Di
Phase 2 · Type 2 Diabetes |
Housey Healthcare ULC | HP-211 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|